NON-INVASIVE FETAL RHD GENOTYPING OF RHD NEGATIVE PREGNANT WOMEN FOR TARGETED ANTI-D THERAPY IN AUSTRALIA: A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Gordon, L. [1 ]
Flower, R. [2 ]
Hyland, C. [2 ]
机构：
[1] IQIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Australian Red Cross Blood Serv, Brisbane, Qld, Australia
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.700
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND4
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [41] Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis
    Zhu, Yu-juan
    Zheng, Ying-ru
    Li, Li
    Zhou, Hao
    Liao, Xi
    Guo, Jian-xin
    Yi, Ping
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2014, 27 (18): : 1839 - 1844
  • [42] Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women
    Darlington, Meryl
    Carbonne, Bruno
    Mailloux, Agnes
    Brossard, Yves
    Levy-Mozziconacci, Annie
    Cortey, Anne
    Maoulida, Hassani
    Simon, Tabassome
    Rousseau, Alexandra
    Durand-Zaleski, Isabelle
    BMC PREGNANCY AND CHILDBIRTH, 2018, 18
  • [43] Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women
    Meryl Darlington
    Bruno Carbonne
    Agnès Mailloux
    Yves Brossard
    Annie Levy-Mozziconacci
    Anne Cortey
    Hassani Maoulida
    Tabassome Simon
    Alexandra Rousseau
    Isabelle Durand-Zaleski
    BMC Pregnancy and Childbirth, 18
  • [44] Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS
    Soothill, P. W.
    Finning, K.
    Latham, T.
    Wreford-Bush, T.
    Ford, J.
    Daniels, G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (12) : 1682 - 1686
  • [45] Non invasive screening for fetal RHD-Genotype in all D-negative women is reliable and cost-effective.
    Van der Schoot, CE
    Soussan, AA
    Bonsel, GJ
    de Haas, M
    BLOOD, 2005, 106 (11) : 165A - 165A
  • [46] Re-audit of cell free foetal DNA (cffDNA) screen to avoid administration of anti-D immunoglobulin in RHD-negative pregnant women with RHD-negative foetus
    Joshi, Nehal
    Bassiony, Sarah
    Mathyalakan, Aruni
    Sugai, Taku
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 14 - 14
  • [47] High-throughput, non-invasive prenatal testing for fetal Rhesus D genotype to guide antenatal prophylaxis with anti-D immunoglobulin: a cost-effectiveness analysis
    Saramago, P.
    Yang, H.
    Llewellyn, A.
    Palmer, S.
    Simmonds, M.
    Griffin, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 (11) : 1414 - 1422
  • [48] Antenatal Fetal RhD Screening using cffDNA in RhD- pregnant women: Time to implement in the NHS; a cost effectiveness analysis at a UK District General Hospital
    Miti, C.
    Jones, M.
    Anwar, K.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 : 6 - 6
  • [49] High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation
    Saramago, Pedro
    Yang, Huiqin
    Llewellyn, Alexis
    Walker, Ruth
    Harden, Melissa
    Palmer, Stephen
    Griffin, Susan
    Simmonds, Mark
    HEALTH TECHNOLOGY ASSESSMENT, 2018, 22 (13) : I - +
  • [50] Evaluation of anti-D antibody in RHD-negative pregnant women in emergency county clinical hospital of Oradea, Romania - A Retrospective study
    Muresan, M.
    Daina, L.
    Micle, O.
    Zaha, D. C.
    Teusdea, L.
    Tica, O.
    Tica, O.
    Naghi, P.
    Antal, L.
    CLINICA CHIMICA ACTA, 2019, 493 : S266 - S266
12345